Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national
11
×
national blog main
san francisco blog main
11
×
san francisco top stories
national top stories
biotech
boston blog main
boston top stories
texas top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
wisconsin blog main
wisconsin top stories
indiana blog main
indiana top stories
fda
cancer
clinical trials
merck
ceo
checkpoint inhibitors
commissioner
crispr
crispr-cas9
drug development
drugs
editas medicine
europe blog main
What
medicine
11
×
cancer
drug
bio
genetic
new
nobel
prize
roundup
cas
cells
crispr
fda
fight
goes
known
marketing
patients
published
researchers
risks
study
treatment
adapt
allison
alzheimer's
amgen
amgen’s
approval
approved
ask
bad
big
biopharma
bosley's
bosley’s
brain
bridge
bucks
cancers
Language
unset
Current search:
national
×
medicine
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
4 years ago
Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More
@xconomy.com
4 years ago
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels
@xconomy.com
5 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Nobel Medicine Prize Honors Cancer Immunotherapy Pioneers Allison & Honjo
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
6 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?